Illumina, Inc., a biotechnology company, held its 2024 annual meeting of stockholders on May 16, 2024. During the meeting, stockholders voted on several key proposals. The first proposal, which was approved, involved the election of Frances Arnold, Caroline Dorsa, Robert Epstein, Scott Gottlieb, Gary Guthart, Stephen MacMillan, Anna Richo, Philip Schiller, Susan Siegel, Jacob Thaysen, and Scott Ullem to the Board of Directors for a one-year term. The second proposal, also approved, ratified the appointment of Ernst & Young LLP as the company's independent registered public accounting firm for the fiscal year ending December 29, 2024. The third proposal, which received advisory approval, was regarding the compensation paid to the company's named executive officers. The detailed voting results for each proposal were disclosed, with the majority of votes cast in favor of the proposed actions. The report was signed by Charles E. Dadswell, General Counsel and Secretary of Illumina, Inc., on May 20, 2024.

Illumina, Inc., a biotechnology company, held its 2024 annual meeting of stockholders on May 16, 2024. During the meeting, stockholders voted on several key proposals. The first proposal, which was approved, involved the election of Frances Arnold, Caroline Dorsa, Robert Epstein, Scott Gottlieb, Gary Guthart, Stephen MacMillan, Anna Richo, Philip Schiller, Susan Siegel, Jacob Thaysen, and Scott Ullem to the Board of Directors for a one-year term. The second proposal, also approved, ratified the appointment of Ernst & Young LLP as the company's independent registered public accounting firm for the fiscal year ending December 29, 2024. The third proposal, which received advisory approval, was regarding the compensation paid to the company's named executive officers. The detailed voting results for each proposal were disclosed, with the majority of votes cast in favor of the proposed actions. The report was signed by Charles E. Dadswell, General Counsel and Secretary of Illumina, Inc., on May 20, 2024.